<DOC>
	<DOCNO>NCT00212004</DOCNO>
	<brief_summary>To evaluate whether pioglitazone could reduce recurrence myocardial infarction patient DM old myocardial infarction</brief_summary>
	<brief_title>Pioglitazone Protects DM Patients Against Re-Infarction ( PPAR Study )</brief_title>
	<detailed_description>Type 2 diabetes mellitus well-established risk factor coronary heart disease atherosclerotic change coronary artery . So designed prospective randomize multi-center trial name pioglitazone could reduce recurrence myocardial infarction patient DM myocardial infarction ( PPAR study ) evaluate whether pioglitazone could reduce recurrence myocardial infarction patient DM ( HbA1c &lt; 6.5 % ) myocardial infarction . 100 hospital participate PPAR study . Patients DM history prior myocardial infarction randomly allocate receive pioglitazone ( 1 ) instructs weight reduction , appropriate diet , regular exercise and/or ( 2 ) prescribes sulfonylurea agent . The number patient recruit 3000 study continue least 2 year . The primary end-points ( 1 ) cardiovascular mortality ( 2 ) hospitalization cardiovascular event . Effects suppression new diabetes development also evaluate . We recognize DM important therapeutic target decrease recurrence cardiovascular event . PPAR study , large scale multi-center trial Japan , provide u new evidence treat DM patient prior myocardial infarction .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>1. diabetes mellitus ( HbA1c &lt; 6.5 % ) 2 . History myocardial infarction 1 . Symptomatic CHF 2 . Type I diabetes 3 . History coronary artery bypass graft 4 . Severe liver and/or kidney dysfunction 5 . History allergic response drug 6. arteriosclerosis obliterans</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2004</verification_date>
	<keyword>diabetes mellitus</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>pioglitazone</keyword>
</DOC>